CGM Use in Adults With Type 2 Diabetes on Basal Insulin
A trial with no phase registered on ClinicalTrials.gov. The registry status is active, not recruiting. It enrolled 469 participants.
Also called NCT05944432
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose treatment
- Phase
- Not applicable
- Enrolled
- 469 participants
- Sponsor
- Registry
-
NCT05944432
-
- Main results
- Continuous glucose monitoring versus self-monitoring of blood glucose in individuals with type 2 diabetes: a randomised, multicentre, open-label, superiority trial
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (anticipated)
- Countries
- United Kingdom
- Registry status
- Active, not recruiting
Technical summary
Registry record NCT05944432. Randomized; no masking; primary purpose treatment. Start 2023-07-26 (actual); primary completion 2026-02-19 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- CGM Use in Adults With Type 2 Diabetes on Basal Insulin
- Condition
- Diabetes Mellitus, Type 2
- Intervention (Device)
- FreeStyle Libre 3 Continuous Glucose Monitoring System.
- Intervention (Device)
- Self monitoring of blood glucose
- Lead sponsor
- Abbott Diabetes Care
Record details
- Record id
cardio:ct-nct05944432- Content hash
295c76586de3c1882938e3f59253c2c92d0a18678c736ab6edf36e12b8852f3b